FindTrial
Sign In

Application research of 3D reconstruction technology in predicting the pathological invasion and surgical prognosis of liver cancer

Application research of 3D reconstruction technology in predicting the pathological invasion and surgical prognosis of liver cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070567
Enrollment
Unknown
Registered
2023-04-17
Start date
2023-04-06
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocelluar carcinoma

Interventions

Gold Standard:Pathological diagnosis, Clinical outcome
Index test:Three-dimensional tumor irregularity

Sponsors

The Third Affiliated Hospital of Navy Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Solitary hepatocellular carcinoma 2. Treated by radical surgical resection 3. Post-operative pathological diagnosis of hepatocellular carcinoma 4. With preoperative 3D reconstruction data

Exclusion criteria

Exclusion criteria: 1. Patients without thin-section scanning 2. Patients with artifacts in the imaging data

Design outcomes

Primary

MeasureTime frame
Tumor irregularity;Area under curve (AUC);Sensitivity;Specificity;Progression-free survival time;—

Secondary

MeasureTime frame
Maximum diameter;—

Countries

China

Contacts

Public ContactHuang Gang

The Third Affiliated Hospital of Navy Military Medical University

squaror@163.com+86 13918663457

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026